BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...
Rohit Bhargava, director of the Cancer Center at Illinois, said that the designation comes with funding from the National ...
A local cancer research center on the University of Illinois campus has received a prestigious designation that comes with funding and opportunities to expand its impact. The Cancer ...
Rohit Bhargava, director of the Cancer Center at Illinois, said that the designation comes with funding from the National ...
Just days after announcing an agreement-in-principle to participate in an outcomes-based methane equivalency process, Alberta ...
Introduction Mindfulness-based interventions are widely used, yet concerns about potential negative effects—particularly those related to mindfulness meditation practice—have gained increasing ...
It is no secret that lawmakers are more interested than ever in artificial intelligence (AI), with over 1,500 AI-related ...
Abdominal wall and hiatal hernia surgery has witnessed profound changes in recent decades, fueled by rapid developments in laparoscopy, robotics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results